ANI Pharmaceuticals Inc (ANIP)
NASDAQ:ANIP

ANI Pharmaceuticals (ANIP) Stock Price & Analysis

228 Followers

ANIP Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$22.31 - $45.50
Previous Close$45.08
Volume52.01K
Average Volume (3M)74.59K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$56.28M
Total Debt (Recent Filing)$286.73M
Price to Earnings (P/E)-10.1
Beta0.78
Next EarningsMar 02, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)-4.48
Shares Outstanding17,453,805
R-Squared0.22
Standard Deviation0.12
10 Day Avg. Volume51,316
30 Day Avg. Volume74,594
Price to Book (P/B)40.31
Price to Sales (P/S)3.48
Price to Cash Flow (P/CF)100.40
P/FCF Ratio-18.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside9.36% Upside
Rating ConsensusModerate Buy
Alpha-0.00741
Number of Analyst Covering2


Financials

Annual

Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

ANIP FAQ

What was ANI Pharmaceuticals’s price range in the past 12 months?
ANI Pharmaceuticals lowest stock price was $22.31 and its highest was $45.50 in the past 12 months.
    What is ANI Pharmaceuticals’s market cap?
    Currently, no data Available
    When is ANI Pharmaceuticals’s upcoming earnings report date?
    ANI Pharmaceuticals’s upcoming earnings report date is Mar 02, 2023 which is in 22 days.
      How were ANI Pharmaceuticals’s earnings last quarter?
      ANI Pharmaceuticals released its earnings results on Nov 09, 2022. The company reported $0.64 earnings per share for the quarter, beating the consensus estimate of $0.552 by $0.088.
        Is ANI Pharmaceuticals overvalued?
        According to Wall Street analysts ANI Pharmaceuticals’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does ANI Pharmaceuticals pay dividends?
          ANI Pharmaceuticals does not currently pay dividends.
          What is ANI Pharmaceuticals’s EPS estimate?
          ANI Pharmaceuticals’s EPS estimate is $0.7.
            How many shares outstanding does ANI Pharmaceuticals have?
            ANI Pharmaceuticals has 17,453,806 shares outstanding.
              What happened to ANI Pharmaceuticals’s price movement after its last earnings report?
              ANI Pharmaceuticals reported an EPS of $0.64 in its last earnings report, beating expectations of $0.552. Following the earnings report the stock price went down -9.2%.
                Which hedge fund is a major shareholder of ANI Pharmaceuticals?
                Among the largest hedge funds holding ANI Pharmaceuticals’s share is Defender Capital, LLC.. It holds ANI Pharmaceuticals’s shares valued at 771K.

                  ---

                  ANI Pharmaceuticals Stock Smart Score

                  5
                  Neutral
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Positive
                  20 days / 200 days
                  Momentum
                  17.48%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  -25.67%
                  Trailing 12-Months
                  Asset Growth
                  57.11%
                  Trailing 12-Months
                  The ANI Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  ANI Pharmaceuticals Inc

                  ANI Pharmaceuticals, Inc. is a pharmaceutical company, which engages in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.

                  ---

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Collegium Pharmaceutical
                  Belite Bio, Inc. ADR
                  Provention Bio
                  Third Harmonic Bio, Inc.

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis